Controlled production of the elusive metastable form II of acetaminophen (paracetamol): a fully scalable templating approach in a cooling environment.

A scalable, transferable, cooling crystallisation route to the elusive, metastable, form II of the API acetaminophen (paracetamol) has been developed using a multicomponent "templating" approach, delivering 100% polymorphic phase pure form II at scales up to 120 g. Favourable solubility and stability properties are found for the form II samples.

[1]  Z. Nagy,et al.  Effects of a structurally related substance on the crystallization of paracetamol , 2013, Frontiers of Chemical Science and Engineering.

[2]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[3]  G Nichols,et al.  Physicochemical characterization of the orthorhombic polymorph of paracetamol crystallized from solution. , 1998, Journal of pharmaceutical sciences.

[4]  N. Rodríguez-Hornedo,et al.  Pharmaceutical cocrystals and poorly soluble drugs. , 2013, International journal of pharmaceutics.

[5]  J. Garside,et al.  Crystallization Kinetics from MSMPR Crystallizers , 1980 .

[6]  Geoff G. Z. Zhang,et al.  Phase transformation considerations during process development and manufacture of solid oral dosage forms. , 2004, Advanced drug delivery reviews.

[7]  C. Sudha,et al.  Supersaturation dependent nucleation control and separation of mono, ortho and unstable polymorphs of paracetamol by swift cooling crystallization technique , 2013 .

[8]  C. Sudha,et al.  Polymer-Induced Selective Nucleation of Mono or Ortho Polymorphs of Paracetamol through Swift Cooling of Boiled Aqueous Solution , 2014 .

[9]  M. Davies,et al.  The effects of additives on the growth and morphology of paracetamol (acetaminophen) crystals. , 2004, International journal of pharmaceutics.

[10]  T. Lu,et al.  Improving the Solubility of Lenalidomide via Cocrystals , 2014 .

[11]  Limin Shi,et al.  Baicalein-nicotinamide cocrystal with enhanced solubility, dissolution, and oral bioavailability. , 2014, Journal of pharmaceutical sciences.

[12]  Tu Lee,et al.  Large-Scale Crystallization of a Pure Metastable Polymorph by Reaction Coupling , 2014 .

[13]  J. Burley,et al.  Enforcing Ostwald's rule of stages: isolation of paracetamol forms III and II. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[14]  Sreenu Bhanoth,et al.  New polymorphs of curcumin. , 2011, Chemical communications.

[15]  Chick C. Wilson,et al.  Paracetamol Form II: An Elusive Polymorph through Facile Multicomponent Crystallization Routes , 2011 .

[16]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[17]  S. Bourne,et al.  New polymorphs of isonicotinamide and nicotinamide. , 2011, Chemical communications.

[18]  M. Neumann,et al.  Crystal structure determination of the elusive paracetamol Form III. , 2009, Chemical communications.

[19]  J. Guyot,et al.  Compression Behavior of Orthorhombic Paracetamol , 1998, Pharmaceutical Research.

[20]  Yongsun Choi,et al.  Polymorph Transformation in Paracetamol Monitored by In-line NIR Spectroscopy During a Cooling Crystallization Process , 2011, AAPS PharmSciTech.

[21]  R. Holm,et al.  Use of pharmaceutical salts and cocrystals to address the issue of poor solubility. , 2013, International journal of pharmaceutics.

[22]  B. Trout,et al.  Polymorphic control by heterogeneous nucleation - A new method for selecting crystalline substrates , 2011 .

[23]  David R. Weyna,et al.  Impact of pharmaceutical cocrystals: the effects on drug pharmacokinetics , 2014, Expert opinion on drug metabolism & toxicology.

[24]  Alastair J. Florence,et al.  Oscillatory flow reactors (OFRs) for continuous manufacturing and crystallization , 2015 .

[25]  A. Choudhury,et al.  New Polymorphs of Fluconazole: Results from Cocrystallization Experiments , 2012 .